Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Apr 20, 2022

Keywords

ClinConnect Summary

This clinical trial is studying Chronic Thromboembolic Pulmonary Hypertension (CTEPH), a serious condition that can occur after a blood clot in the lungs. The trial aims to better understand how certain patterns in proteins in the blood can help doctors diagnose this condition more accurately. If you or a loved one is experiencing shortness of breath and has had tests showing possible lung issues, you might be eligible to participate in this study. To join, participants need to have specific test results indicating a suspicion of CTEPH and will need a procedure called right heart catheterization to confirm their diagnosis.

Participants in this trial will receive careful monitoring and evaluation at specialized centers, where doctors will conduct the necessary tests to assess their condition. It's important to note that only patients with certain lung scan results can join, and those with normal results or those under legal guardianship cannot participate. If you meet the criteria and are interested, you will receive detailed information about the study and what to expect throughout the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with a suspicion of Chronic thromboembolic pulmonary hypertension (CTEPH) with a combination of a perfusion lung scan and transthoracic perfusion scan and transthoracic echocardiography compatible with the diagnosis (according to French recommendations)
• • Patients who require a right heart catheterization.
• • Patient affiliated or entitled to a social security plan
• • Patient having received informed information about the study informed about the study
• Exclusion Criteria:
• • Patient with a normal perfusion lung scan
• • Person under legal guardianship